Quarterly report · Q2
2370.TEDINET S100QQH6
Period2022-10-01 → 2023-03-31
Filed2023-05-12
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥349m | 2022-10-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥634m | 2021-10-01 → 2022-09-30 | Standalone | Net sales (5-year summary) |
| Revenue | ¥318m | 2021-10-01 → 2022-03-31 | Standalone | Net sales |
| Operating income | −¥672m | 2022-10-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | −¥678m | 2021-10-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | −¥670m | 2022-10-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥1.3bn | 2021-10-01 → 2022-09-30 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥676m | 2021-10-01 → 2022-03-31 | Standalone | Ordinary income |
| Profit before tax | −¥674m | 2022-10-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥676m | 2021-10-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | −¥677m | 2022-10-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | −¥1.3bn | 2021-10-01 → 2022-09-30 | Standalone | Net income loss (5-year summary) |
| Net income | −¥679m | 2021-10-01 → 2022-03-31 | Standalone | Profit loss |
| Total assets | ¥5.4bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥6.1bn | at 2022-09-30 | Standalone | Assets |
| Total assets | ¥6.3bn | at 2022-03-31 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥529m | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥566m | at 2022-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥4.9bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥5.5bn | at 2022-09-30 | Standalone | Net assets |
| Net assets / equity | ¥5.6bn | at 2022-03-31 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥4.0bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.5bn | at 2022-09-30 | Standalone | Cash and deposits |
| Cash & equivalents | ¥4.0bn | at 2023-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.5bn | at 2022-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.3bn | at 2022-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.1bn | at 2021-09-30d | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥564m | 2022-10-01 → 2023-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.2bn | 2021-10-01 → 2022-09-30 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥612m | 2021-10-01 → 2022-03-31 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥35m | 2022-10-01 → 2023-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥20m | 2021-10-01 → 2022-09-30 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥23m | 2021-10-01 → 2022-03-31 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥133m | 2022-10-01 → 2023-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.6bn | 2021-10-01 → 2022-09-30 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥885m | 2021-10-01 → 2022-03-31 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥-3.19 | 2022-10-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.66 | 2023-01-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6.33 | 2021-10-01 → 2022-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.63 | 2021-10-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.75 | 2022-01-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 89.6% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.7% | at 2022-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.3% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 213,465,757 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 211,730,423 | at 2022-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 197,000,423 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | −¥313m |
| jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥276,000 |
| jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥276,000 |
| jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥225m |
| jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥349m |
| jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥349m |
| jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥133m |
| —segment total | revenue | 2022-10-01 → 2023-03-31 | ¥349m |
| —segment total | revenue external | 2022-10-01 → 2023-03-31 | ¥349m |
| —segment total | segment profit | 2022-10-01 → 2023-03-31 | −¥358m |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-03-31 | −¥265m |
| jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥69,000 |
| jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥69,000 |
| jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | −¥308m |
| jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥318m |
| jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥318m |
| jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | −¥105m |
| —segment total | revenue | 2021-10-01 → 2022-03-31 | ¥318m |
| —segment total | revenue external | 2021-10-01 → 2022-03-31 | ¥318m |
| —segment total | segment profit | 2021-10-01 → 2022-03-31 | −¥413m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 461
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report non consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)普 賢 監 査 法 人 | |
| Cpa1 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)嶋 田 両 児 | |
| Cpa2 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)髙 橋 弘 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | 318089000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | 349413000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 633672000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | -676225000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | -669664000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -1314262000 | JPY |
| Net income loss (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | -678928000 | JPY |
| Net income loss (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | -676572000 | JPY |
| Net income loss (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -1254092000 | JPY |
| Equity in earnings losses of affiliates if equity method is applied (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | － | JPY |
| Equity in earnings losses of affiliates if equity method is applied (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | － | JPY |
| Equity in earnings losses of affiliates if equity method is applied (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | JPY |
| Capital stock (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 5534253000 | JPY |
| Capital stock (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 5214960000 | JPY |
| Capital stock (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 5892020000 | JPY |
| Total number of issued shares (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 197000423 | |
| Total number of issued shares (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 213465757 | |
| Total number of issued shares (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 211730423 | |
| Net assets (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 5647193000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 4852519000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 5511924000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 6311621000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 5381331000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 6078061000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | -3.63 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | -3.19 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -6.33 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | |
| Dividend paid per share (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | － | |
| Dividend paid per share (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | － | |
| Dividend paid per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 0.893 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 0.896 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 0.907 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | -612097000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | -563797000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -1161202000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | -23361000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | -34933000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -20227000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | 884559000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | 133355000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 1584835000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |